Company NexgenRx Inc.

Equities

NXG

CA65337X1042

Investment Management & Fund Operators

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Investment Management & Fund Operators

Market Closed - Toronto S.E. Other stock markets 02:47:14 2024-05-17 pm EDT			5-day change	1st Jan Change
0.29 ^CAD	+20.83%		+26.09%	+31.82%

May. 17	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 16	Charles Burns Tenders Resignation as Director of NexgenRx Inc	CI

NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications in a of software-as-a-service model. The Companyâs products include NexSys, NexAdmin, NexPension and NexPSPAssist. The NexSys product platform provides solution and simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. Its NexPension product is an advanced pension administration solution designed to help sponsors record and tabulate contributions for their membership group in a multi-employer environment. Its platform makes self-administration a reality.

Number of employees: 20

CAD in Million	2022	Weight	2023	Weight	Delta
Administration Fees 45.9 %	5	35.6 %	6	45.9 %	+39.72%
Transaction Fees 37.4 %	6	50.2 %	5	37.4 %	-19.32%
Consulting 12.1 %	2	11.9 %	2	12.1 %	+9.71%
Other 4.0 %	0	1.6 %	1	4.0 %	+169.38%
Commission 0.6 %	0	0.7 %	0	0.6 %	-4.75%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	13	100.0 %	14	100.0 %	+8.33%

Managers	Title	Age	Since
Ronald Campbell Loucks FOU	Founder	-	03-03-12
Kelly Tyler Elher DFI	Director of Finance/CFO	61	16-12-04
Jason Robinson ADM	Chief Administrative Officer	-	17-12-31
Mark Payne CTO	Chief Tech/Sci/R&D Officer	-	21-08-23
Andrew Munroe COO	Chief Operating Officer	-	17-01-31
Paul Freedman CTO	Chief Tech/Sci/R&D Officer	-	-
Doreen Harvey HRO	Human Resources Officer	-	-
Avik Debroy AUD	Comptroller/Controller/Auditor	-	-
Paul Anthony Bolger SEC	Corporate Secretary	-	21-06-10

Members of the board	Title	Age	Since
Ronald Campbell Loucks FOU	Founder	-	03-03-12
Thomas F. Corcoran CHM	Chairman	-	06-03-06
Charles Burns BRD	Director/Board Member	-	17-06-15
Randy E. McGlynn BRD	Director/Board Member	-	18-08-21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	70,921,820	44,907,032 ( 63.32 %)	0	63.32 %
Stock B	0	6,600,000	0	0

Name	Equities	%	Valuation
Paul Everett Crossett 19.99 %	14,098,638	19.99 %	2 M $
Ronald Campbell Loucks 10.40 %	7,335,108	10.40 %	1 M $
Charles Burns 5.467 %	3,855,667	5.467 %	620 762 $
Thomas F. Corcoran 0.8867 %	625,375	0.8867 %	100 685 $
Randy E. McGlynn 0.1418 %	100,000	0.1418 %	16 100 $

Name	Equities	%	Valuation
Ronald Campbell Loucks 13.79 %	800,000	13.79 %	128 800 $
Paul Everett Crossett 11.38 %	660,000	11.38 %	106 260 $
Thomas F. Corcoran 6.897 %	400,000	6.897 %	64 400 $

NexgenRx, Inc.

191 The West Mall Suite 905

M9C 5L6, Toronto

http://www.nexgenrx.com

Financials

Banking & Investment Services

Investment Banking & Investment Services

Investment Management & Fund Operators

Other Investment Management & Fund Operators

	1st Jan change	Capi.
NEXGENRX INC.	+31.82%	15.12M
UBS GROUP AG	+5.52%	97.29B
BROOKFIELD CORPORATION	+13.89%	68.9B
APOLLO GLOBAL MANAGEMENT, INC.	+21.34%	64.34B
BANK OF NEW YORK MELLON CORPORATION (THE)	+14.31%	44.5B
AMERIPRISE FINANCIAL, INC.	+14.29%	43.12B
3I GROUP PLC	+22.18%	36.25B
T. ROWE PRICE GROUP INC.	+8.42%	26.07B
STATE STREET CORPORATION	+0.71%	23.5B
PRINCIPAL FINANCIAL GROUP, INC.	+8.24%	19.95B

Other Investment Management & Fund Operators